-
1دورية أكاديمية
المؤلفون: Damon Asher, Daisy Dai, Alexa C. Klimchak, Lauren E. Sedita, Katherine L. Gooch, Louise Rodino-Klapac
المصدر: Molecular Therapy: Methods & Clinical Development, Vol 30, Iss , Pp 474-483 (2023)
مصطلحات موضوعية: delandistrogene moxeparvovec, Duchenne muscular dystrophy, gene therapy, rare disease, scientific spillover, SRP-9001, Genetics, QH426-470, Cytology, QH573-671
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S232905012300116XTest; https://doaj.org/toc/2329-0501Test
-
2دورية أكاديمية
المؤلفون: Alexa C. Klimchak, Lauren E. Sedita, Louise R. Rodino-Klapac, Jerry R. Mendell, Craig M. McDonald, Katherine L. Gooch, Daniel C. Malone
المصدر: Journal of Market Access & Health Policy, Vol 11, Iss 1 (2023)
مصطلحات موضوعية: Cost-effectiveness analysis, delandistrogene moxeparvovec, Duchenne muscular dystrophy, gene therapy, SRP-9001, Public aspects of medicine, RA1-1270, Business, HF5001-6182
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/2001-6689Test
-
3دورية أكاديمية
المؤلفون: Irfan Khan, Eric D. Peterson, Christopher P. Cannon, Lauren E. Sedita, Jay M. Edelberg, Kausik K. Ray
المصدر: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 15 (2020)
مصطلحات موضوعية: atherosclerotic cardiovascular disease, ezetimibe, low‐density lipoprotein cholesterol, PCSK9 inhibitor, statin, Diseases of the circulatory (Cardiovascular) system, RC666-701
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/2047-9980Test
-
4
المصدر: Journal of Managed Care & Specialty Pharmacy. 29:472-479
مصطلحات موضوعية: Health Policy, Pharmaceutical Science, Pharmacy
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a1278f09e59949f6aa838382534d16fdTest
https://doi.org/10.18553/jmcp.2023.22363Test -
5
مصطلحات موضوعية: Health Policy
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae0bb55ae7aa017e10b78a5913926da8Test
-
6
المؤلفون: Lauren E. Sedita, Jay M. Edelberg, Kausik K. Ray, Eric D. Peterson, Irfan Khan, Christopher P. Cannon
المصدر: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
e016506مصطلحات موضوعية: Oncology, medicine.medical_specialty, Statin, Time Factors, medicine.drug_class, PCSK9 inhibitor, Low density lipoprotein cholesterol, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Ezetimibe, Risk Factors, Internal medicine, Cardiovascular Disease, Secondary Prevention, Medicine, Humans, 030212 general & internal medicine, Preventive Cardiology, 1102 Cardiorespiratory Medicine and Haematology, Original Research, Hypolipidemic Agents, Randomized Controlled Trials as Topic, Lipids and Cholesterol, business.industry, Atherosclerotic cardiovascular disease, low‐density lipoprotein cholesterol, statin, atherosclerotic cardiovascular disease, Models, Theoretical, Primary Prevention, Cardiovascular Diseases, Heart Disease Risk Factors, Treatment strategy, Lipid lowering, Cardiology and Cardiovascular Medicine, business, medicine.drug, ezetimibe
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69bcfb379d7c7a52235d1a51338dad3aTest
http://europepmc.org/articles/PMC7792260Test